-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39

Benzinga·08/06/2026 15:31:05
Listen to the news
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $39.